Indian Journal of Sleep Medicine

Register      Login

VOLUME 9 , ISSUE 1 ( January-March, 2014 ) > List of Articles


Association Between Sleep Duration and Glycemic Control Among Patients with Type 2 Diabetes Mellitus in India

Anil C Mathew, Elvin Benny, Jenit A Osborn, Senthil Kumar Rajasekaran, Suresh R Prabu, Ma Yunsheng

Keywords : Sleep duration, Glycemic level, Type 2 diabetes mellitus

Citation Information : Mathew AC, Benny E, Osborn JA, Rajasekaran SK, Prabu SR, Yunsheng M. Association Between Sleep Duration and Glycemic Control Among Patients with Type 2 Diabetes Mellitus in India. Indian Sleep Med 2014; 9 (1):22-28.

DOI: 10.5958/0974-0155.2014.01102.4

License: CC BY-SA 4.0

Published Online: 01-03-2018

Copyright Statement:  Copyright © 2014; The Author(s).


Context: An increasing prevalence of type 2 diabetes mellitus is a growing public health concern in India. The problem of chronic partial sleep loss due to changes in lifestyle is also rapidly increasing. Aim: The aim of the present study was to examine the association between sleep duration and glycemic level (HbA1c) in type 2 diabetic patients. Settings and design: This was a tertiary care hospital based cross-sectional study in India. Materials and methods: A total of 202 patients with type 2 diabetes mellitus aged 20 years and above attending an endocrinology outpatient clinic during the month of July 2013 were studied. Information on glycosylated haemoglobin (HbA1c) value, sleep duration, age, gender, duration of diabetes, total energy intake, current smoking, current alcohol consumption, insulin use, depressive symptoms and Body Mass Index (BMI) were obtained. Results: The adjusted mean (95% Confidence Interval (CI)) HbA1c values for subjects who slept less than 4.5 hours (h) was 9.90% (8.76, 11.19), for subjects who slept 4.5 – 6.4 h was 8.42% (8.04, 8.81), for subjects who slept 6.5 – 8.4 h was 8.18% (7.77, 8.63) and for subjects who slept more than 8.5 h was 8.28% (7.04, 9.74). Log mean HbA1c between those who slept less than 4.5 h was significantly higher compared to the subjects who slept 6.5-8.4 h (P = 0.011) and the subjects who slept 4.5-6.4 h (P = 0.013). Significant interactions were observed between sleep duration and age (<50 years and e”50 years) (P for interaction = 0.026). On the other hand, there was no significant interaction between sleep duration and gender, the presence or absence of obesity and depressive symptoms. However a significant interaction was observed between sleep duration and use of insulin therapy (P for interaction = 0.001) in predicting HbA1c. Conclusion: This is the first epidemiological study in India to investigate the U-shaped associations of sleep duration with glycemic level in patients with type 2 diabetes mellitus. Our observations suggested that the patients with short sleep duration particularly among the elderly without insulin use should be considered high risk patients for poor glycemic control. Future studies can look into the optimal sleep duration required which may be considered as an important modifiable factor for the clinical management of patients with type 2 diabetes mellitus.

PDF Share
  1. Shaw, J.E., Sicree, R.A. and Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010; 87(1) :4–14.
  2. Abegunde, D.O., Mathers, C.D., Adam, T., Ortegon, M. and Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370 :1929-1938.
  3. Hjelm, K., Mufunda, E., Nambozi, G. and Kemp, J. Preparing nurses to face the pandemic of diabetes mellitus: a literature review. Journal of Advanced Nursing2003; 41 :424-434.
  4. Mohan, V., Sandeep, S., Deepa, R., Shah, B. and Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian Journal of Medical Research2007; 125(3) :217-30.
  5. Mohan, V., Deepa, R., Shanthirani, C.S. and Premalatha, G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in south India. Journal of the American College of Cardiology 2001; 38(3) : 682–7.
  6. Premalatha, G., Shanthirani, C.S., Deepa, R., Markovitz, J. and Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected south Indian population – The Chennai Urban Population Study (CUPS). Diabetes Care 2000; 23(9) : 1295–300.
  7. Kawakami, N., Takatsuka, N. and Shimizu, H. Sleep disturbance and onset of type 2 diabetes. Diabetes Care2004; 27 : 282-283.
  8. Knutson, K.L., Ryden, A.M., Mander, B.A. and Van Cauter, E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166 :1768–1774.
  9. Trento, M., Broglio, F., Riganti, F., et al. Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol 2008; 45 : 225–229.
  10. Knutson, K.L., Van Cauter, E., Zee, P., Liu, K. and Lauderdale, D.S. Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care 2011; 34 : 1171–1176.
  11. Chaput, J.P., Després, J.P., Bouchard, C. and Tremblay, A. The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep 2008 ;31 : 517–523.
  12. Taheri, S., Lin, L., Austin, D., Young, T. and Mignot, E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. Public Library of Science Medicine 2004 ; 1(3) : 210–217.
  13. Gottlieb, D.J., Redline, S., Nieto, F.J., et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006 ;29 : 1009–1014.
  14. Ferrie, J.E., Shipley, M.J., Cappuccio, F.P., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007;30 : 1659–1666.
  15. Ayas, N.T., White, D.P., Manson, J.E., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003; 163: 205–209.
  16. Beihl, D.A., Liese, A.D. and Haffner, S.M. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Annals of Epidemiology 2009;19: 351–357.
  17. Vishnu, A., Shankar, A. and Kalidindi, S. Examination of the association between insufficient sleep and cardiovascular disease and diabetes by race/ethnicity. International Journal of Endocrinology, 2011 ; 789358.
  18. Buysse, D.J., Reynolds, C.F. III, Monk, T.H., Berman, S.B. and Kupfer, D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research 1989 ; 28 : 193-213.
  19. Van Poppel, M.N.M., Chinapaw, M.J.M., Mokkink, L.B., van Mechelen, W. and Terwee, C.B. Physical activity questionnaires for adults: A systematic review of measurement properties. Sports Medicine 2010 ; 40 : 565-600.
  20. Ainsworth, B.E., Haskell, W.L., Leon, A.S., Jacobs, D.R., Montoye, H.J., Sallis, J.F. and Paffenbarger, R.S. Compendium of physical activities: classification of energy costs of human physical activities. Medicine and Science in Sports and Exercise 1993; 25(1) : 71–80.
  21. Radloff, L. The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977 ;1 : 385-401.
  22. National institute of nutrition Hyderbad. Dietary guidelines for Indians A manual: 2010.
  23. Ainsworth, B.E., Haskell, W.L., Whitt, M.C., Irwin, M.L., Swartz, A.M., Strath, S.J., O'Brien, W.L., Bassett, D.R., Schmitz, K.H., Emplaincourt, P.O., et al. Compendium of physical activities: an update of activity codes and MET intensities. Medicine and Science in Sports and Exercise 2000 ; 32(9) : 498–516.
  24. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organization Technical Report Series 1995;854 : 1–452.
  25. Ohkuma, T., Fujii, H., Iwase, M., Kikuchi, Y., Ogata, S., Idewaki, Y., Ide, H., Doi, Y., Hirakawa, Y., Nakamura, U. and Kitazono T. Impact of sleep duration on obesity and the glycemic level in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Diabetes Care 2013 ; 36(3) : 611-7.
  26. Spiegel, K., Tasali, E., Penev, P. and Van Cauter, E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine 2004 ; 141 : 846–850.
  27. Brondel, L., Romer, M.A., Nougues, P.M., Touyarou, P. and Davenne, D. Acute partial sleep deprivation increases food intake in healthy men. American Journal of Clinical Nutrition 2010 ; 91: 1550–1559.
  28. Spiegel, K., Leproult, R. and Van Cauter, E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999 ; 354 : 1435–1439.
  29. Vgontzas, A.N., Zoumakis, E., Bixler, E.O., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. The Journal of Clinical Endocrinology & Metabolism 2004 ; 89 : 2119– 2126.
  30. Ayas, N.T., White, D.P., Al-Delaimy, W.K., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003; 26 : 380–384.
  31. Yaggi, H.K., Araujo, A.B. and McKinlay, J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006 ; 29 : 657–661.
  32. Gangwisch, J.E., Heymsfield, S.B., Boden- Albala, B., et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007; 30 : 1667–1673.
  33. Beihl, D.A., Liese, A.D. and Haffner, S.M. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Annals of Epidemiology2009; 19: 351–357.
  34. Tuomilehto, H., Peltonen, M., Partinen, M., et al. Finnish Diabetes Prevention Study Group. Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabetes Care 2009 ; 32 : 1965–1971.
  35. Patel, S.R., Malhotra, A., Gottlieb, D.J., White, D.P. and Hu, F.B. Correlates of long sleep duration. Sleep 2006; 29 : 881–889.
  36. Amagi, Y., Ishikawa, S., Gotoh, T., Doi, Y., Kayaba, K., Nakamura, Y., et al. Sleep duration and mortality in Japan:the Jichi medical school cohort study. J Epidemiol 2004 ;14 : 124–128.
  37. Patel, S.R., Ayas, N.T., Malhotra, M.R., White, D.P., Schernhammer, E.S., Speizer, F.E., et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004 ; 27 : 440–444.
  38. Tamakoshi, A. and Ohno, Y. JACC study group: self-reported sleep duration as a predictor of all-cause mortality :result from the JACC study, Japan. Sleep 2004; 27 : 51–54.
  39. Kojima, M., Wakai, K., Kawamura, T., Tamakoshi, A., Aoki, R., Lin, Y., et al. Sleep patterns and total motality: a 12-year follow-up study in Japan. J Epidemiol 2000 ; 10 : 87–93.
  40. Gangwisch, J.E., Heymsfield, S.B., Boden-Albala, B., Buijs, R.M., Kreier, F., Pickering, T.G., et al. Short sleep duration as a risk factor for hypertension:analyses of the first National Health and Nutriton Examination Survey. Hypertension 2006 ; 47 : 833–839.
  41. Ganwisch, J.E., Malaspina, D., Boden-Albala, B. and Heymsfield, S.B. Inadequate sleep as a risk factor for obesity: analyses of the NHANESI. Sleep 2005 ; 28 : 1289– 1296.
  42. Nakajima, H., Kaneita, Y., Yokoyama, E., Harano, S., Tamaki, T., Ibuka, E., Kaneko, A., Takahashi, I., Umeda, T., Nakaji, S. and Ohida, T. Association between sleep duration and hemoglobin A1c level. Sleep Med 2008 ; 9(7) : 745- 52.
  43. Frankel, B.L., Coursey, R.D., Buchbinder, R., et al. Recorded and reported sleep in chronic primary insomnia. Arch Gen Psychiatry 1976 ; 33 : 615–623.
  44. Hoch, C.C., Reynolds, C.F., Kupfer, D.J., Berman, S.R., Houck, P.R. and Stack, J.A. Empirical note: self-report versus recorded sleep in healthy seniors. Psychophysiology 1987 ; 24 : 293–299.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.